UVADEX Sterile Solution


Approval Status
Approved February 1999

Treatment for

Cancer & Oncology

UVADEX (methoxsalen) Sterile Solution with the UVARĀ® Photopheresis System has been approved for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.

UVADEX Sterile Solution Drug Information

The UVADEX Sterile Solution drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top